Premier Anti-Aging Co., Ltd. : Increase of volatility
Entry price | Target | Stop-loss | Potential |
---|
JP¥18,330 |
JP¥26,000 |
JP¥14,000 |
+41.84% |
---|
Premier Anti-Aging Co., Ltd. shares have been in strong demand lately. The technical chart pattern looks positive which may give rise to new gains.
Strengths● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● For the past twelve months, EPS forecast has been revised upwards.
Weaknesses●
● With an expected P/E ratio at 47.21 and 37.39 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
● The company's enterprise value to sales, at 4.82 times its current sales, is high.
●
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.